+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Surface Markers Market 2024-2028

  • PDF Icon

    Report

  • 166 Pages
  • October 2023
  • Region: Global
  • TechNavio
  • ID: 5515037
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cell surface markers market is forecasted to grow by USD 14068.95 mn during 2023-2028, accelerating at a CAGR of 8.25% during the forecast period. The report on the cell surface markers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by COVID-19 pandemic impact, increasing demand for precision medicine, and increasing use of diagnostics.

The cell surface markers market is segmented as below:

By Application

  • Disease diagnosis
  • Research
  • drug discovery

By Product

  • Antibody
  • PCR array

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increased use of diagnostics in cancer detection as one of the prime reasons driving the cell surface markers market growth during the next few years. Also, increasing popularity of flow cytometry technique and integration of artificial intelligence and machine learning will lead to sizable demand in the market.

The report on the cell surface markers market covers the following areas:

  • Cell surface markers market sizing
  • Cell surface markers market forecast
  • Cell surface markers market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell surface markers market vendors that include Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Cell Signaling Technology Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Grifols SA, IVD Medical Holding Ltd., Johnson and Johnson, PerkinElmer Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Werfenlife SA. Also, the cell surface markers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global cell surface markers market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global cell surface markers market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Disease diagnosis - Market size and forecast 2023-2028
Exhibit 34: Chart on Disease diagnosis - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Disease diagnosis - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Disease diagnosis - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Disease diagnosis - Year-over-year growth 2023-2028 (%)
6.4 Research and drug discovery - Market size and forecast 2023-2028
Exhibit 38: Chart on Research and drug discovery - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Research and drug discovery - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Research and drug discovery - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Research and drug discovery - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
Exhibit 42: Market opportunity by Application ($ million)
Exhibit 43: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 44: Chart on Product - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 Antibody - Market size and forecast 2023-2028
Exhibit 48: Chart on Antibody - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Antibody - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Antibody - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Antibody - Year-over-year growth 2023-2028 (%)
7.4 PCR array - Market size and forecast 2023-2028
Exhibit 52: Chart on PCR array - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on PCR array - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on PCR array - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on PCR array - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 56: Market opportunity by Product ($ million)
Exhibit 57: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 83: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 107: Abbott Laboratories - Overview
Exhibit 108: Abbott Laboratories - Business segments
Exhibit 109: Abbott Laboratories - Key news
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus
12.4 Abcam plc
Exhibit 112: Abcam plc - Overview
Exhibit 113: Abcam plc - Product/Service
Exhibit 114: Abcam plc - Key news
Exhibit 115: Abcam plc - Key offerings
12.5 Agilent Technologies Inc.
Exhibit 116: Agilent Technologies Inc. - Overview
Exhibit 117: Agilent Technologies Inc. - Business segments
Exhibit 118: Agilent Technologies Inc. - Key offerings
Exhibit 119: Agilent Technologies Inc. - Segment focus
12.6 Becton Dickinson and Co.
Exhibit 120: Becton Dickinson and Co. - Overview
Exhibit 121: Becton Dickinson and Co. - Business segments
Exhibit 122: Becton Dickinson and Co. - Key news
Exhibit 123: Becton Dickinson and Co. - Key offerings
Exhibit 124: Becton Dickinson and Co. - Segment focus
12.7 Bio Rad Laboratories Inc.
Exhibit 125: Bio Rad Laboratories Inc. - Overview
Exhibit 126: Bio Rad Laboratories Inc. - Business segments
Exhibit 127: Bio Rad Laboratories Inc. - Key offerings
Exhibit 128: Bio Rad Laboratories Inc. - Segment focus
12.8 Danaher Corp.
Exhibit 129: Danaher Corp. - Overview
Exhibit 130: Danaher Corp. - Business segments
Exhibit 131: Danaher Corp. - Key news
Exhibit 132: Danaher Corp. - Key offerings
Exhibit 133: Danaher Corp. - Segment focus
12.9 DiaSorin SpA
Exhibit 134: DiaSorin SpA - Overview
Exhibit 135: DiaSorin SpA - Business segments
Exhibit 136: DiaSorin SpA - Key news
Exhibit 137: DiaSorin SpA - Key offerings
Exhibit 138: DiaSorin SpA - Segment focus
12.10 F. Hoffmann La Roche Ltd.
Exhibit 139: F. Hoffmann La Roche Ltd. - Overview
Exhibit 140: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 141: F. Hoffmann La Roche Ltd. - Key news
Exhibit 142: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 143: F. Hoffmann La Roche Ltd. - Segment focus
12.11 Grifols SA
Exhibit 144: Grifols SA - Overview
Exhibit 145: Grifols SA - Business segments
Exhibit 146: Grifols SA - Key offerings
Exhibit 147: Grifols SA - Segment focus
12.12 Johnson and Johnson
Exhibit 148: Johnson and Johnson - Overview
Exhibit 149: Johnson and Johnson - Business segments
Exhibit 150: Johnson and Johnson - Key news
Exhibit 151: Johnson and Johnson - Key offerings
Exhibit 152: Johnson and Johnson - Segment focus
12.13 PerkinElmer Inc.
Exhibit 153: PerkinElmer Inc. - Overview
Exhibit 154: PerkinElmer Inc. - Business segments
Exhibit 155: PerkinElmer Inc. - Key news
Exhibit 156: PerkinElmer Inc. - Key offerings
Exhibit 157: PerkinElmer Inc. - Segment focus
12.14 QIAGEN NV
Exhibit 158: QIAGEN NV - Overview
Exhibit 159: QIAGEN NV - Product/Service
Exhibit 160: QIAGEN NV - Key news
Exhibit 161: QIAGEN NV - Key offerings
12.15 Sysmex Corp.
Exhibit 162: Sysmex Corp. - Overview
Exhibit 163: Sysmex Corp. - Business segments
Exhibit 164: Sysmex Corp. - Key offerings
Exhibit 165: Sysmex Corp. - Segment focus
12.16 Thermo Fisher Scientific Inc.
Exhibit 166: Thermo Fisher Scientific Inc. - Overview
Exhibit 167: Thermo Fisher Scientific Inc. - Business segments
Exhibit 168: Thermo Fisher Scientific Inc. - Key news
Exhibit 169: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 170: Thermo Fisher Scientific Inc. - Segment focus
12.17 Werfenlife SA
Exhibit 171: Werfenlife SA - Overview
Exhibit 172: Werfenlife SA - Product/Service
Exhibit 173: Werfenlife SA - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 174: Inclusions checklist
Exhibit 175: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 176: Currency conversion rates for US$
13.4 Research methodology
Exhibit 177: Research methodology
Exhibit 178: Validation techniques employed for market sizing
Exhibit 179: Information sources
13.5 List of abbreviations
Exhibit 180: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global cell surface markers market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Application - Market share 2023-2028 (%)
Exhibits 31: Data Table on Application - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Disease diagnosis - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Disease diagnosis - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Disease diagnosis - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Disease diagnosis - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Research and drug discovery - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Research and drug discovery - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Research and drug discovery - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Research and drug discovery - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Application ($ million)
Exhibits 43: Data Table on Market opportunity by Application ($ million)
Exhibits 44: Chart on Product - Market share 2023-2028 (%)
Exhibits 45: Data Table on Product - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by Product
Exhibits 47: Data Table on Comparison by Product
Exhibits 48: Chart on Antibody - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Antibody - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Antibody - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Antibody - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on PCR array - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on PCR array - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on PCR array - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on PCR array - Year-over-year growth 2023-2028 (%)
Exhibits 56: Market opportunity by Product ($ million)
Exhibits 57: Data Table on Market opportunity by Product ($ million)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ million)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 101: Impact of drivers and challenges in 2023 and 2028
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Abbott Laboratories - Overview
Exhibits 108: Abbott Laboratories - Business segments
Exhibits 109: Abbott Laboratories - Key news
Exhibits 110: Abbott Laboratories - Key offerings
Exhibits 111: Abbott Laboratories - Segment focus
Exhibits 112: Abcam plc - Overview
Exhibits 113: Abcam plc - Product/Service
Exhibits 114: Abcam plc - Key news
Exhibits 115: Abcam plc - Key offerings
Exhibits 116: Agilent Technologies Inc. - Overview
Exhibits 117: Agilent Technologies Inc. - Business segments
Exhibits 118: Agilent Technologies Inc. - Key offerings
Exhibits 119: Agilent Technologies Inc. - Segment focus
Exhibits 120: Becton Dickinson and Co. - Overview
Exhibits 121: Becton Dickinson and Co. - Business segments
Exhibits 122: Becton Dickinson and Co. - Key news
Exhibits 123: Becton Dickinson and Co. - Key offerings
Exhibits 124: Becton Dickinson and Co. - Segment focus
Exhibits 125: Bio Rad Laboratories Inc. - Overview
Exhibits 126: Bio Rad Laboratories Inc. - Business segments
Exhibits 127: Bio Rad Laboratories Inc. - Key offerings
Exhibits 128: Bio Rad Laboratories Inc. - Segment focus
Exhibits 129: Danaher Corp. - Overview
Exhibits 130: Danaher Corp. - Business segments
Exhibits 131: Danaher Corp. - Key news
Exhibits 132: Danaher Corp. - Key offerings
Exhibits 133: Danaher Corp. - Segment focus
Exhibits 134: DiaSorin SpA - Overview
Exhibits 135: DiaSorin SpA - Business segments
Exhibits 136: DiaSorin SpA - Key news
Exhibits 137: DiaSorin SpA - Key offerings
Exhibits 138: DiaSorin SpA - Segment focus
Exhibits 139: F. Hoffmann La Roche Ltd. - Overview
Exhibits 140: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 141: F. Hoffmann La Roche Ltd. - Key news
Exhibits 142: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 143: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 144: Grifols SA - Overview
Exhibits 145: Grifols SA - Business segments
Exhibits 146: Grifols SA - Key offerings
Exhibits 147: Grifols SA - Segment focus
Exhibits 148: Johnson and Johnson - Overview
Exhibits 149: Johnson and Johnson - Business segments
Exhibits 150: Johnson and Johnson - Key news
Exhibits 151: Johnson and Johnson - Key offerings
Exhibits 152: Johnson and Johnson - Segment focus
Exhibits 153: PerkinElmer Inc. - Overview
Exhibits 154: PerkinElmer Inc. - Business segments
Exhibits 155: PerkinElmer Inc. - Key news
Exhibits 156: PerkinElmer Inc. - Key offerings
Exhibits 157: PerkinElmer Inc. - Segment focus
Exhibits 158: QIAGEN NV - Overview
Exhibits 159: QIAGEN NV - Product/Service
Exhibits 160: QIAGEN NV - Key news
Exhibits 161: QIAGEN NV - Key offerings
Exhibits 162: Sysmex Corp. - Overview
Exhibits 163: Sysmex Corp. - Business segments
Exhibits 164: Sysmex Corp. - Key offerings
Exhibits 165: Sysmex Corp. - Segment focus
Exhibits 166: Thermo Fisher Scientific Inc. - Overview
Exhibits 167: Thermo Fisher Scientific Inc. - Business segments
Exhibits 168: Thermo Fisher Scientific Inc. - Key news
Exhibits 169: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 170: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 171: Werfenlife SA - Overview
Exhibits 172: Werfenlife SA - Product/Service
Exhibits 173: Werfenlife SA - Key offerings
Exhibits 174: Inclusions checklist
Exhibits 175: Exclusions checklist
Exhibits 176: Currency conversion rates for US$
Exhibits 177: Research methodology
Exhibits 178: Validation techniques employed for market sizing
Exhibits 179: Information sources
Exhibits 180: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global cell surface markers market: Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Cell Signaling Technology Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Grifols SA, IVD Medical Holding Ltd., Johnson and Johnson, PerkinElmer Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Werfenlife SA.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increased use of diagnostics in cancer detection.'

According to the report, one of the major drivers for this market is the COVID-19 pandemic impact.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • Bio Techne Corp.
  • Cell Signaling Technology Inc.
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • GenScript Biotech Corp.
  • Grifols SA
  • IVD Medical Holding Ltd.
  • Johnson and Johnson
  • PerkinElmer Inc.
  • QIAGEN NV
  • Siemens Healthineers AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Werfenlife SA